Sun BioPharma, Inc. Summarizes SBP-101 Phase 1 Clinical Data Presented at ASCO 2020 Annual Gastrointestinal Cancers Symposium


You May Also Like

Surface Oncology Reports Financial Results and Corporate Highlights for Third Quarter 2018

CAMBRIDGE, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology company ...

Crown Bioscience Announces Merger with JSR Corporation

SAN DIEGO, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of ...